Back to News
investment

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside

Seeking Alpha
Loading...
4 min read
0 likes
⚡ Quantum Brief
The healthcare distributor’s 2025 buy rating was reaffirmed in April 2026 despite a recent stock dip, citing strong fundamentals including global reach and niche clinical service roles. Its $1.1B acquisition of EyeSouth’s retina-care business expands specialty offerings, signaling strategic growth in high-margin healthcare segments. A decade-long dividend growth streak, low payout ratio, and Fitch’s "A-level" credit rating underscore financial stability amid thin operational margins. Regulatory and pricing pressures remain sector risks, though the company’s diversified footprint and profitability help mitigate exposure. The analyst highlights long-term upside potential, emphasizing resilience across market cycles and a disciplined capital allocation strategy.
AI Audio Summary
0:00 / 0:00
Click to play
559501b0-87d1-48a4-96bd-eed638de8323.jpeg
Quantum News · Media Library

Albert Anthony1.72K FollowersFollow5ShareSavePlay(15min)CommentsSummaryCencora (COR) gets its prior buy rating from 2025 reaffirmed, driven by several strong fundamentals, despite a recent price retreat.The healthcare distributor has a global brand footprint, a key role in serving specific clinical needs, and profitability, despite thin margins.The dividend case is compelling, with proven 10 year growth across many market cycles, and a low payout ratio.Fitch gave this company an "A-level" credit rating.The sector risk of regulations and pricing pressure has also been discussed. YurolaitsAlbert/iStock via Getty Images A Healthcare Supplier Eyeing The Competition Seeing is believing, and recently I saw a late-March piece in Reuters on healthcare distributor Cencora (COR) buying out the retina-care business of EyeSouth for $1.1B, so I thoughtThis article was written byAlbert Anthony1.72K FollowersFollowAlbert Anthony is the pen name of a business author on Amazon and his newest book is "How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis," now available as a 2026 edition paperback and Kindle ebook in several regions including the US, UK, Canada, and Europe. The author is an analyst & contributor for investing platform Seeking Alpha since 2023, where he has nearly 2,000 followers and has covered hundreds of stocks in multiple sectors including banks/financials, REITs, insurance, pharma, and more. He has also written for platforms like Investing dot com, and has taken part in many business conferences includes Bloomberg Adria's Investment Outlook 2026 as well as Money Motion 2026. Albert Anthony has Croatian-American roots, having grown up in the US and living in the NYC/New Jersey area as well as the Austin Texas area while working in enterprise IT roles at several prominent companies, including a top 10 financial firm. The author earned a B.A. from Drew University, and also completed certifications from Microsoft, CompTIA, and Corporate Finance Institute where he earned the specialization in risk management. He is founder of a boutique equities research firm, Albert Anthony & Company, which is a trade name both in the US and Croatia. Besides his writing and analyst work, the author has been active on camera as well, as a film/TV extra for casting agencies in Croatia/Europe, and also took part in roundtable panel discussions and appeared in several media stories in that region. You can also check out the author's video content on the Albert Anthony channel on YouTube where he discusses investing topics, @author.albertanthony Please note: The author does not write about non-publicly traded companies, small cap stocks, crypto, or startup CEOs, so any such mail received and pitches from PR agencies will be deleted. Any official mail to the author should be sent to albertanthony.info@gmail.com. *Author Disclaimer: Albert Anthony and Albert Anthony & Co, is a US-based sole proprietorship registered as a trade name in Austin, Texas, and a sole proprietor registered in Croatia. The author nor his company are registered financial advisors and do not provide personalized financial advisory services to clients and do not manage client assets but provide general markets commentary and research as well as actionable insights based on publicly-available data and their own analysis. The author does not sell or market financial products and services, nor is compensated by any company for rating them. The author does not hold any material position in any stock he rates at the time of writing, unless otherwise disclosed. All investment is assumed to be at risk and readers are expected to do their due diligence beyond the scope of this author's commentary, agreeing to indemnify the author of any liability for potential investment losses.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.